Gene ID | Gene Symbol | Description | Source |
---|---|---|---|
3956 | LGALS1 | galectin 1 | |
3958 | LGALS3 | galectin 3 | |
3964 | LGALS8 | galectin 8 | |
3965 | LGALS9 | galectin 9 | |
4360 | MRC1 | mannose receptor C-type 1 | |
4595 | MUTYH | mutY DNA glycosylase | |
4684 | NCAM1 | neural cell adhesion molecule 1 | |
4907 | NT5E | 5'-nucleotidase ecto | |
4952 | OCRL | OCRL inositol polyphosphate-5-phosphatase | |
4973 | OLR1 | oxidized low density lipoprotein receptor 1 |
Gene ID | Gene Symbol | Description | Source |
---|---|---|---|
12015 | Bad | BCL2-associated agonist of cell death | |
16002 | Igf2 | insulin-like growth factor 2 | |
16333 | Ins1 | insulin I | |
16334 | Ins2 | insulin II | |
16846 | Lep | leptin | |
18605 | Enpp1 | ectonucleotide pyrophosphatase/phosphodiesterase 1 | |
18708 | Pik3r1 | phosphoinositide-3-kinase regulatory subunit 1 | |
74155 | Errfi1 | ERBB receptor feedback inhibitor 1 |
Gene ID | Gene Symbol | Description | Source |
---|---|---|---|
24483 | Igf2 | insulin-like growth factor 2 | |
24505 | Ins1 | insulin 1 | |
24506 | Ins2 | insulin 2 | |
25513 | Pik3r1 | phosphoinositide-3-kinase regulatory subunit 1 | |
25608 | Lep | leptin | |
64639 | Bad | BCL2-associated agonist of cell death | |
85496 | Enpp1 | ectonucleotide pyrophosphatase/phosphodiesterase 1 | |
313729 | Errfi1 | ERBB receptor feedback inhibitor 1 |
UniProt ID | Protein Name | Source |
---|---|---|
P16112 | Aggrecan core protein | |
P16278 | Beta-galactosidase | |
P16442 | Histo-blood group ABO system transferase | |
P16444 | Dipeptidase 1 | |
P16581 | E-selectin | |
P17931 | Galectin-3 | |
P18669 | Phosphoglycerate mutase 1 | |
P18827 | Syndecan-1 | |
P19174 | 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-1 | |
P19320 | Vascular cell adhesion protein 1 |
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01
GlyCosmos Portal v4.0.0
Last updated: August 19, 2024